Cohance Lifesciences Reports Rs 45.19 Crore Q1 Loss
Cohance Lifesciences reported a consolidated loss of Rs 45.19 crore for the quarter ended June, against a profit of Rs 46.40 crore a year earlier. Total income fell to Rs 434.51 crore…
Business & Economy3 months ago
Cohance Lifesciences reported a consolidated loss of Rs 45.19 crore for the quarter ended June, against a profit of Rs 46.40 crore a year earlier. Total income fell to Rs 434.51 crore…
Business & Economy3 months ago
Shares in Cohance Lifesciences rose more than 2% even after the company reported a weak June quarter, with a net loss of Rs 24.1 crore against a year-earlier profit of Rs 48.9…
All of India’s news in one place, summarised from multiple outlets so you can read more in less time. Every story links back to the original reporting.



Ashin Xavier: interesting
IO Repro: Repro test v4 after fix 2 Oct. Safe to trash.
IO Repro: Repro test v3 after fix 2 Oct. Safe to trash.
IO Repro: Repro test after fix 2 Oct. Safe to trash.